Determination of platelet and fibrinogen half-life with [75Se]selenomethionine: studies in normal and in diabetic subjects. 1975

J C Ferguson, and N Mackay, and J A Philip, and D J Sumner

1. Simultaneous platelet and fibrinogen survival studies were carried out on a group of seven normal persons and eleven diabetic patients. 2. Survival time was calculated: (a) by measuring the interval between 50% of the maximum radioactivity in the anabolic phase and 50% of the maximum radioactivity in the catabolic phase, and (b) by fitting an exponential function to the decay phase of the curve. 3. With the first method, the normal group had a mean plaetelet survival which did not differ significantly from that in the diabetic group. With the second method, however, the platelet half-life in the diabetic patients was significantly shorter than in the normal subjects. 4. Fibrinogen survival was significantly shorter in the diabetic group with either method. 5. It is concluded that there is an increased utilization of platelets and fibrinogen in diabetic subjects.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012643 Selenium An element with the atomic symbol Se, atomic number 34, and atomic weight 78.97. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE. Selenium-80,Selenium 80

Related Publications

J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
April 1974, British journal of haematology,
J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
June 1975, Thrombosis et diathesis haemorrhagica,
J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
April 1968, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
December 1969, British medical journal,
J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
December 1966, Revue de neuropsychiatrie infantile et d'hygiene mentale de l'enfance,
J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
May 1971, British journal of haematology,
J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
January 1978, Acta medica Academiae Scientiarum Hungaricae,
J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
November 1975, The British journal of nutrition,
J C Ferguson, and N Mackay, and J A Philip, and D J Sumner
July 1973, The British journal of nutrition,
Copied contents to your clipboard!